Granulomatous amoebic encephalitis laboratory tests: Difference between revisions
Created page with "{{Granulomatous amoebic encephalitis}} {{CMG}} ==Overview== '''Granulomatous amoebic encephalitis''' is a central nervous system disease caused by certain species of [[..." |
m Changes made per Mahshid's request |
||
| (6 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Granulomatous amoebic encephalitis}} | {{Granulomatous amoebic encephalitis}} | ||
| Line 4: | Line 5: | ||
==Overview== | ==Overview== | ||
The [[indirect immunofluorescence assay]] (IFA) is a test used to detect antibodies attached to Balamuthia amebas in body tissues. In contrast, [[immunohistochemistry]] (IHC) uses specific antibodies against Balamuthia to detect the amoebas. Finally, a [[polymerase chain reaction]] (PCR) molecular assay can detect Balamuthia DNA. | |||
==Laboratory Findings== | |||
Balamuthia Granulomatous Amebic Encephalitis (GAE) is a serious infection of the [[brain]] and [[spinal cord]] caused by Balamuthia. GAE is often diagnosed only after death. However, it can be diagnosed by examining [[blood]], [[cerebrospinal fluid]], and tissue samples from a living patient as well. Diagnosis of GAE in a living patient is less common because the amoebas are difficult to identify under the microscope, even with commonly used stains[5]. | |||
However, there are three types of tests that can help confirm the diagnosis of GAE. The [[indirect immunofluorescence assay]] (IFA) is a test used to detect antibodies attached to Balamuthia amebas in body tissues. In contrast, [[immunohistochemistry]] (IHC) uses specific antibodies against Balamuthia to detect the amoebas. Finally, a [[polymerase chain reaction]] (PCR) molecular assay can detect Balamuthia DNA. | |||
The [[Centers for Disease Control and Prevention]] (CDC) offers diagnostic assistance for Balamuthia to physicians and scientists through DPDx. | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Disease]] | |||
[[Category:Neurology]] | |||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{wikiDoc Sources}} | {{wikiDoc Sources}} | ||
Latest revision as of 17:50, 18 September 2017
|
Granulomatous amoebic encephalitis Microchapters |
|
Differentiating Granulomatous amoebic encephalitis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Granulomatous amoebic encephalitis laboratory tests On the Web |
|
American Roentgen Ray Society Images of Granulomatous amoebic encephalitis laboratory tests |
|
Granulomatous amoebic encephalitis laboratory tests in the news |
|
Blogs on Granulomatous amoebic encephalitis laboratory tests |
|
Directions to Hospitals Treating Granulomatous amoebic encephalitis |
|
Risk calculators and risk factors for Granulomatous amoebic encephalitis laboratory tests |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
The indirect immunofluorescence assay (IFA) is a test used to detect antibodies attached to Balamuthia amebas in body tissues. In contrast, immunohistochemistry (IHC) uses specific antibodies against Balamuthia to detect the amoebas. Finally, a polymerase chain reaction (PCR) molecular assay can detect Balamuthia DNA.
Laboratory Findings
Balamuthia Granulomatous Amebic Encephalitis (GAE) is a serious infection of the brain and spinal cord caused by Balamuthia. GAE is often diagnosed only after death. However, it can be diagnosed by examining blood, cerebrospinal fluid, and tissue samples from a living patient as well. Diagnosis of GAE in a living patient is less common because the amoebas are difficult to identify under the microscope, even with commonly used stains[5].
However, there are three types of tests that can help confirm the diagnosis of GAE. The indirect immunofluorescence assay (IFA) is a test used to detect antibodies attached to Balamuthia amebas in body tissues. In contrast, immunohistochemistry (IHC) uses specific antibodies against Balamuthia to detect the amoebas. Finally, a polymerase chain reaction (PCR) molecular assay can detect Balamuthia DNA.
The Centers for Disease Control and Prevention (CDC) offers diagnostic assistance for Balamuthia to physicians and scientists through DPDx.
References